← Back to Search

Behavioural Intervention

Online Health Support for Endometrial Cancer (RESILIENCE Trial)

N/A
Recruiting
Led By Carla Prado, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 16, and week 24
Awards & highlights

RESILIENCE Trial Summary

This trial tests a web-platform with online healthcare support to improve health outcomes in endometrial cancer survivors.

Who is the study for?
This trial is for adults over 18 who've had low-grade, early-stage endometrial cancer and are 1-5 years post-surgery. They should have a BMI between 30 and 45, speak English, but not be pregnant or have metal implants that affect imaging tests. Those with eating disorders, recent weight changes, uncontrolled diabetes or thyroid issues, on certain medications, very active or on strict diets aren't eligible.Check my eligibility
What is being tested?
The RESILIENCE trial is testing an online health platform called My Viva Plan along with professional support to see if it helps reduce waist size and improve health in survivors of endometrial cancer over a period of 24 weeks.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes supported by an online platform and healthcare professionals rather than medication or surgery, typical medical side effects are not expected. Participants may experience the usual risks associated with changing diet and exercise habits.

RESILIENCE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 16, and week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 16, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in waist circumference at week 16.
Secondary outcome measures
Change from baseline in abdominal adiposity by MRI at week 24.
Change from baseline in abdominal skeletal muscle by MRI at week 24.
Change from baseline in adipose tissue in liver by MRI at week 24.
+14 more

RESILIENCE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment2 Interventions
Participants will receive the intervention for 24 weeks. The first 16 weeks will involve an intensive behavioral program (digital wellness platform plus online healthcare professional support), followed by an 8-week maintenance period (digital wellness platform alone). At baseline, participants will receive handouts with publicly available health information; they will also wear an activity monitor and receive support telephone calls for the 24 weeks.
Group II: Control groupActive Control1 Intervention
At baseline, participants will receive handouts with publicly available health information; they will also wear an activity monitor and receive support telephone calls for the 24 weeks.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
384,986 Total Patients Enrolled
Carla Prado, PhDPrincipal InvestigatorUniversity of Alberta
8 Previous Clinical Trials
473 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for participants in this experiment?

"According to the information available on clinicaltrials.gov, this particular study is no longer recruiting patients for participation. The trial was initially posted in November of 2023 and last updated in September of that same year. Even though this specific medical research is not looking for candidates, there are currently 313 other trials actively searching for participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial
Carla Prado 2024. "ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06038032.
~99 spots leftby Mar 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top